What Is a Reduced-Intensity Stem Cell Transplant?

A reduced-intensity stem cell transplant, also known as a ‘mini’ transplant, is a modified form of a procedure that replaces a patient’s blood-forming stem cells with those of a compatible donor. Mini-transplant patients receive lower doses of chemotherapy than are used in a full-intensity, or myeloablative, transplant, and, in general, receive no radiation therapy. The … Read more

Whipple Operation: What It Is, Side Effects, Follow-Up

What is the Whipple operation/procedure? Many pancreatic cancer patients are diagnosed after the cancer has spread beyond the pancreas, making surgery a risky treatment option. But for those patients whose cancer is localized, surgery may be used to remove the tumor and prevent further spread. When the tumor is confined to the head or neck of the pancreas, … Read more

Drug Prolongs Remissions in Some Relapsed Ovarian Cancers

Ed. note: Niraparib (Zejula) was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2017, as a maintenance therapy for women with ovarian, fallopian tube, or primary peritoneal cancer. This post was originally published on Oct. 21, 2016. For women with relapsed ovarian cancer that responds to platinum-based chemotherapy, a drug that hampers … Read more

What Are Aromatase Inhibitors?

Aromatase inhibitors are drugs given to patients with hormone-receptor-positive breast cancer (HR+). They target the aromatase enzyme, which helps produce female hormones such as estrogen. Estrogen drives the growth of many HR+ tumors, and these drugs help control estrogen production, says Harold Burstein, MD, PhD, a breast cancer specialist in the Susan F. Smith Center … Read more

Can Marijuana Benefit Cancer Patients?

Early research has shown cannabis may be helpful for patients experiencing side effects from chemotherapy and other types of cancer treatment, such as nausea and vomiting. But there are also risk associated with using cannabis, and the persisting social stigma and legal questions surrounding its use complicate how it is approached in a clinical setting.  … Read more

Cancer Conversations Podcast—Episode #17: The Latest in Brain Tumor Research and Treatment

Brain tumors can be among the most challenging cancers to treat. The blood-brain barrier, a natural defense mechanism that shields the brain from harm, can also prevent cancer treatments from reaching tumors. “It can be difficult to get treatments effectively into the brain,” says David Reardon, MD, clinical director of Dana-Farber’s Center for Neuro-Oncology. However, … Read more

What Is ‘Watchful Waiting’ and When Is it Right for Prostate Cancer?

According to the American Cancer Society, more than 180,000 men will be diagnosed with prostate cancer this year, with African American men 60 percent more likely to develop the disease than other ethnic groups. Fortunately, the vast majority of prostate cancer diagnoses will be a slow-growing, highly treatable form of the disease. For many men diagnosed … Read more

Treatments for Ovarian Cancer: Finding Your Path [Infographic]

Ovarian cancer is a complex disease. Cell types, stages, and genetics play an important role for patients and their doctors as they decide which direction to take. Fortunately, patients today have many treatment options and new advances on the horizon. Physician-scientists at the Susan F. Smith Center for Women’s Cancers are leading the way in … Read more

Cancer Conversations Podcast—Episode #16: The Latest in Prostate Cancer Treatment and Research

Prostate cancer affects 230,000 men each year. Although diagnoses are increasing worldwide, most people die with prostate cancer and not of prostate cancer, according to Mark Pomerantz, MD, a medical oncologist in Dana-Farber’s Lank Center for Genitourinary Oncology. In this Cancer Conversations podcast episode, Pomerantz discusses genetics, risk factors, and the controversy surrounding the PSA … Read more

New Treatment Protocol Boosts Survival in Pediatric Neuroblastoma Patients

When Emily Coughlin complained of a sore knee in May 2009, doctors initially suspected Lyme disease. After antibiotics failed to relieve the pain, the girl, who was just shy of her fourth birthday, was diagnosed with neuroblastoma, a cancer that begins in nerve cells outside the brain and usually affects children under 6. Though rare … Read more

What is an Angiogenesis Inhibitor and How Can It Be Used to Treat Cancer?

Tumors can’t grow any larger than the size of a pinhead unless the body generates a network of new blood vessels to nourish them – a process known as angiogenesis. So using drugs called angiogenesis inhibitors to block this process is an ingenious strategy with many potential advantages over standard chemotherapy. Indeed, when the first … Read more

Clinical Trial Helps Betsy Brauser Live with Ovarian Cancer

As researchers and clinicians in the Susan F. Smith Center for Women’s Cancers at Dana-Farber continue studying the benefits of a two-drug combination in slowing progression of recurrent ovarian cancer, one patient is as a beacon of hope for her caregivers – and for others facing the disease. Betsy Brauser, treated with standard chemotherapy near … Read more

Voices Podcast – Episode #4: Mastectomy, or Not — Breast Cancer Surgery Decisions

When Judy Rosenbaum was diagnosed with breast cancer, the thought of serious treatment and surgery, like a mastectomy, was frightening. Working with her doctors and care team, Judy found a “less is more” treatment approach and elected to have a lumpectomy rather than a mastectomy. “I was terrified of having surgery,” Rosenbaum says. “The only … Read more

Cancer Conversations Podcast – Episode #11: Advances in Pediatric Brain Tumor Treatment

Perhaps more than any other childhood cancer, pediatric brain tumor treatment is incredibly complex and takes a team effort to care for a patient. Doctors and researchers are working to not only improve medicines and treatment methods, they are also striving to improve quality of life and long-term side effects for young patients. “The goal … Read more